LYEL

Lyell Immunopharma, Inc. Common Stock

24.73

USD

LYEL Earnings Reports

Positive Surprise Ratio

LYEL beat 14 of 18 last estimates.

78%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$2.41

Implied change from Q3 25 (Revenue/ EPS)

-100.00%

+13.15%

Implied change from Q4 24 (Revenue/ EPS)

-100.00%

-39.75%

Lyell Immunopharma, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, LYEL reported earnings of -2.13 USD per share (EPS) for Q3 25, beating the estimate of -2.69 USD, resulting in a 20.98% surprise. Revenue reached 15.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -1.25% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -2.41 USD, with revenue projected to reach -- USD, implying an increase of 13.15% EPS, and decrease of -100.00% in Revenue from the last quarter.

FAQ

What were Lyell Immunopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Lyell Immunopharma, Inc. Common Stock reported EPS of -$2.13, beating estimates by 20.98%, and revenue of $15.00K, 0% as expectations.

How did the market react to Lyell Immunopharma, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -1.25%, changed from $17.63 before the earnings release to $17.41 the day after.

When is Lyell Immunopharma, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Lyell Immunopharma, Inc. Common Stock's next earnings report?

Based on 6 analysts, Lyell Immunopharma, Inc. Common Stock is expected to report EPS of -$2.41 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.